The Laboratory of Pharmaceutical Nanotechnology is constantly striving to promote the concept of "Nanosimilarity" and in this context, it has published a number of papers, as well as submitted comments on the existing European Medicines Agency (EMA) guidelines of certain products. The utilization of high-tech techniques and knowledge that is new to the field of Pharmaceutical Sciences contributes to this effort.
Contribution to the Creation of EMA Guidelines
- The group of the Laboratory of Pharmaceutical Nanotechnology, has recently published several research articles focusing on the fractal morphology of nanoparticles. In the same context, a comment regarding the “Concept paper on the revision of the guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins (EMA/ CHMP/BMWP/42832/2005)” was submitted to the European Medicines Agency (EMA).
- Recently, from our research group (there are several publications concerning the thermotropic behavior of nanoparticles) a comment on “Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission (EMA/ CHMP/BWP/187338/2014)” was submitted to the European Medicines Agency (EMA).
Papers on Nanosimilarity
- Fractal geometry as a new approach for proving nanosimilarity: A reflection note. C. Demetzos, N. Pippa. International Journal of Pharmaceutics, 2015.
- Fractal analysis as a complementary approach to predict the stability of drug delivery nano systems in aqueous and biological media: A regulatory proposal or a dream? C. Demetzos, N. Pippa.
International Journal of Pharmaceutics, 2014. - The significance of drug to lipid ratio to the development of optimized liposomal formulation. M. Chountoulesi, N. Naziris, N. Pippa, C. Demetzos. Journal of Liposome Research, 2017.
- The Thermal Analysis of Liposomal Formulations as an Element to Evaluate their Effectiveness as Drug and Vaccine Delivery Systems. N. Naziris, N. Pippa, S. Pispas, C. Demetzos. In: Liposomes: Historical, Clinical, and Molecular Perspectives, Ed: B.R. Pearson, Nova Science Publishers, 2017. Abstract Available.